<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Results</title>
    <link rel="stylesheet" href="./lib/css/styles.css">
</head>
<body class="results">
<p><strong>Asymptomatic patient. Low risk for coronary artery disease. Initial imaging.</strong></p>
Advice from ACR  - https://acsearch.acr.org/docs/3082570/Narrative/
<p><strong>&nbsp;</strong></p>
<p><strong>CT Coronary Calcium is usually appropriate, </strong></p>
<p><strong>CTA Coronary Arteries with IV Contrast may be appropriate.</strong></p>
<p><strong>No other imaging is usually appropriate.</strong></p>
<p><strong>&nbsp;</strong></p>
<p><strong>CT Coronary Calcium</strong></p>
<p>Kondos&nbsp; et&nbsp; al&nbsp; [24]&nbsp; found&nbsp; that&nbsp; any&nbsp; measurable&nbsp; coronary&nbsp; calcium&nbsp; was&nbsp; independently&nbsp; related&nbsp; to&nbsp; hard&nbsp; (death&nbsp; and&nbsp; myocardial&nbsp; infarction)&nbsp; and&nbsp; soft&nbsp; (revascularization&nbsp; procedure)&nbsp; events&nbsp; in&nbsp; men&nbsp; and&nbsp; women&nbsp; at&nbsp; low&nbsp; to&nbsp; intermediate pretest risk; this finding provided incremental prognostic information over conventional risk factors.Many&nbsp; trials&nbsp; have&nbsp; found&nbsp; evidence&nbsp; of&nbsp; the&nbsp; prognostic&nbsp; use&nbsp; of&nbsp; a CAC&nbsp; score.&nbsp; Shaw&nbsp; et&nbsp; al&nbsp; [25]&nbsp; followed&nbsp; 10,377&nbsp; asymptomatic&nbsp; patients&nbsp; for&nbsp; 5&nbsp; &plusmn;&nbsp; 3.5&nbsp; years&nbsp; and&nbsp; found&nbsp; a&nbsp; CAC&nbsp; score&nbsp; to&nbsp; be&nbsp; an&nbsp; independent&nbsp; predictor&nbsp; of&nbsp; death&nbsp; that&nbsp; increased proportionally relative to baseline, with an adjusted relative risk of 1.6, 1.7, 2.5, and 4 for CAC scores of 11 to 100, 101 to 400, 401 to 1,000, and &gt;1,000, respectively. Budoff et al [26] also demonstrated incremental risk beyond age, gender, ethnicity, and cardiac risk factors, in evaluating data from 25,253 asymptomatic patients who had a 10-year adjusted survival rate of 99.4% for a CAC score of 0, and 87.8% for a score &gt;1,000. In the CARDIAstudy, of the 2,831 participants, the CAC score and prevalence increased, and an increase in FRS with a score &gt;0 was observed in 7.3%, 20.2%, 19.1%, and 44.8% of individuals with FRSs of 0% to 2.5%, 2.6% to 5%, 5.1% to 10%, and &gt;10%, respectively. A CAC score of &ge;100 was observed in 1.3%, 2.4%, and 3.5% of those with FRSs of 0% to 2.5%, 2.6% to 5%, and 5.1% to 10%, respectively, without significant change in stratification according to sex&nbsp; and&nbsp; race.&nbsp; The&nbsp; yield&nbsp; of&nbsp; CAC&nbsp; was&nbsp; deemed&nbsp; considerable&nbsp; in&nbsp; the intermediate-risk&nbsp; group&nbsp; [27].&nbsp; Additionally,&nbsp; the MESA&nbsp;&nbsp; of&nbsp;&nbsp; 6,779&nbsp;&nbsp; initially&nbsp; &nbsp;asymptomatic&nbsp;&nbsp; individuals&nbsp;&nbsp; also&nbsp;&nbsp; showed&nbsp;&nbsp; CAC&nbsp;&nbsp; as&nbsp;&nbsp; an&nbsp;&nbsp; independent&nbsp;&nbsp; predictor&nbsp;&nbsp; of&nbsp;&nbsp; cerebrovascular events when CAC analysis was stratified by sex or race or ethnicity and improved discrimination for a cerebrovascular event when added to the full model (C-statistic: 0.744 versus 0.755) [28]. Although the authors of the study do not specify the pretest risk of the overall patient population, the presence of hypertension and treated hypertension as well as the degree of coronary calcification was higher in the group containing individuals whohad cerebrovascular events.In&nbsp; the&nbsp; MESA,&nbsp; Polonsky&nbsp; et&nbsp; al&nbsp; [29]&nbsp; used the CAC&nbsp; score,&nbsp; in&nbsp; conjunction&nbsp; with&nbsp; their&nbsp; conventional&nbsp; FRS,&nbsp; to&nbsp; evaluate&nbsp; 5,878 asymptomatic men and women. In that study, the net reclassification index was 25%, an additional 23% of subjects&nbsp; with&nbsp; events&nbsp; were&nbsp; reclassified&nbsp; to&nbsp; the&nbsp; high-risk&nbsp; category,&nbsp; and&nbsp; 13%&nbsp; of&nbsp; subjects&nbsp; without&nbsp; events&nbsp; were&nbsp; reclassified&nbsp; to&nbsp; the&nbsp; low-risk&nbsp; category&nbsp; [29].&nbsp; The&nbsp; Heinz&nbsp; Nixdorf&nbsp; Recall study,&nbsp; a&nbsp; large&nbsp; population-based&nbsp; study&nbsp; with&nbsp; nearly&nbsp; 5,000&nbsp; participants&nbsp; and&nbsp; a&nbsp; 5-year&nbsp; follow-up,&nbsp; demonstrated&nbsp; a&nbsp; net&nbsp; reclassification&nbsp; index&nbsp; of&nbsp; 24%&nbsp; and&nbsp; 19%&nbsp; as&nbsp; high-&nbsp;&nbsp;&nbsp; and&nbsp;&nbsp;&nbsp; low-risk&nbsp;&nbsp;&nbsp; groups,&nbsp;&nbsp;&nbsp; respectively [30].&nbsp;&nbsp;&nbsp; The&nbsp;&nbsp;&nbsp; recent&nbsp;&nbsp;&nbsp; AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA&nbsp; guideline&nbsp; on&nbsp; the&nbsp; management&nbsp; of&nbsp; blood&nbsp; cholesterol&nbsp; also&nbsp; suggests&nbsp; patients&nbsp; with a 10-year risk of 5% to 7.5% (borderline risk) in the presence of risk-enhancing factors, such as family history, of&nbsp; premature&nbsp; ASCVD;&nbsp; persistently&nbsp; elevated&nbsp; LDL-C&nbsp; levels&nbsp; &ge;160&nbsp; mg/dL;&nbsp; metabolic&nbsp; syndrome;&nbsp; chronic&nbsp; kidney&nbsp; disease;&nbsp; history&nbsp; of&nbsp; preeclampsia;&nbsp; or&nbsp; premature&nbsp; menopause&nbsp; (age&nbsp; &lt;40&nbsp; years);&nbsp; chronic&nbsp; inflammatory&nbsp; disorders&nbsp; (eg, rheumatoid arthritis, psoriasis, or chronic HIV); high-risk ethnic groups (eg, South Asian); and persistent elevations of triglycerides &ge;175 mg/dL may benefit from a CAC score prior to initiating a statin therapy [3]. These studies have&nbsp; shown&nbsp; that CAC&nbsp; score&nbsp; predicts&nbsp; future&nbsp; mortality&nbsp; and&nbsp; major&nbsp; cardiac&nbsp; events&nbsp; and&nbsp; aids&nbsp; in&nbsp; improved&nbsp; risk&nbsp; stratification&nbsp; beyond&nbsp; the&nbsp; conventional&nbsp; risk&nbsp; factor&ndash;based&nbsp; scores&nbsp; alone.&nbsp; A&nbsp; positive&nbsp; calcium&nbsp; score&nbsp; can&nbsp; restratify&nbsp; asymptomatic&nbsp; patients&nbsp; with&nbsp; a&nbsp; family&nbsp; history&nbsp; of&nbsp; premature&nbsp; CAD to&nbsp; a&nbsp; high-risk&nbsp; category&nbsp; and can even&nbsp; reclassify&nbsp; those&nbsp; individuals&nbsp; without&nbsp; risk&nbsp; factors&nbsp; as&nbsp; higher&nbsp; risk&nbsp; than&nbsp; those&nbsp; with&nbsp; multiple&nbsp; risk&nbsp; factors&nbsp; but&nbsp; no&nbsp; coronary&nbsp; artery&nbsp; calcification [31,32].</p>
<p><strong>CTA Coronary Arteries</strong></p>
<p>In&nbsp; a&nbsp; recent&nbsp; study,&nbsp; Di&nbsp; Cesare&nbsp; et&nbsp; al&nbsp; [33]&nbsp; showed&nbsp; utility&nbsp; of&nbsp; CCTA&nbsp; in&nbsp; asymptomatic&nbsp; patients at intermediate&nbsp; risk of stenosis detection in 112 out of 185 (60.5%) patients: 56 patients (30.2%) had mild stenosis, 49 patients (26.5%) had moderate stenosis, only 3 patients (1.6%) had severe stenosis, and in 4 patients (2.2%) evaluation could not be determined.</p>
<p><strong>US Echocardiography Transthoracic Resting</strong></p>
<p>There is no relevant literature supporting the use of TTE resting in asymptomatic patients at intermediate risk of CAD.</p>
<p><strong>US Echocardiography Transthoracic Stress</strong></p>
<p>The sensitivity and specificity of stress TTE is 85% and 89%, respectively, has been validated only in populations at elevated risk, and is best utilized to search for obstructive major epicardial coronary stenosis [34]. There is no relevant literature to support the use of stress TTE in asymptomatic patients at intermediate risk of CAD.</p>
<p><strong>MRA Coronary Arteries</strong></p>
<p>MRA of the coronary arteries can assess for arterial patency and pathologic wall thickening but not calcific burden, and it cannot reliably assess small distal vessels [35,36]. There is no relevant literature to support the use of MRA of the coronary arteries in asymptomatic patients at intermediate risk of CAD.</p>
<p>&nbsp;</p>
<p><strong>MRI Heart Function with Stress</strong></p>
<p>&nbsp;</p>
<p>The&nbsp; IMPACT&nbsp; II&nbsp; study&nbsp; demonstrated&nbsp; a sensitivity&nbsp; of&nbsp; 67%&nbsp; and&nbsp; specificity&nbsp; of&nbsp; 61%&nbsp; for&nbsp; detection&nbsp; of&nbsp; ischemic&nbsp; heart&nbsp; disease,&nbsp; including&nbsp; 533&nbsp; patients&nbsp; in&nbsp; the&nbsp; intermediate-risk&nbsp; population&nbsp; [37].&nbsp; The&nbsp; vast&nbsp; majority&nbsp; of&nbsp; the&nbsp; patients&nbsp; in&nbsp; this&nbsp; study&nbsp; were&nbsp; symptomatic,&nbsp; with&nbsp; angina&nbsp; pectoris.&nbsp; The&nbsp; sensitivity&nbsp; and&nbsp; specificity&nbsp; of&nbsp; the&nbsp; test&nbsp; in&nbsp; the&nbsp; asymptomatic&nbsp; intermediate-risk population has not been validated.</p>
<p><strong>MRI Heart Function and Morphology</strong></p>
<p>There is no relevant literature to support the use of MRI heart function and morphology to evaluate asymptomatic patients at intermediate risk of CAD.</p>
<p><strong>SPECT/CT MPI Rest and Stress</strong></p>
<p>Stress SPECT MPI is the most commonly used stress-imaging technique for patients with suspected or known CAD but&nbsp; has&nbsp; been&nbsp; primarily&nbsp; validated&nbsp; in&nbsp; symptomatic&nbsp; patients,&nbsp; and&nbsp; no&nbsp; studies&nbsp; have&nbsp; examined&nbsp; SPECT&nbsp; MPI&nbsp; alone&nbsp; in&nbsp; asymptomatic intermediate-risk patients. However, in combination with a calcium score of &ge;400, expert consensus has speculated that the test may be used for intermediate-risk patients [38]. However, there is no relevant literature to support the use of SPECT MPI in asymptomatic patients at intermediate risk of CAD, except in diabetic patients or those about to undertake a vigorous exercise program [39].</p><p><strong>References</strong></p>
<ol>
    <li>Cooper R,&nbsp; Cutler&nbsp; J,&nbsp; Desvigne-Nickens&nbsp; P,&nbsp; et&nbsp; al.&nbsp; Trends&nbsp; and&nbsp; disparities&nbsp; in&nbsp; coronary&nbsp; heart&nbsp; disease,&nbsp; stroke,&nbsp; and&nbsp; other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation2000;102:3137-47.</li>
    <li>Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol2010;56:e50-103.</li>
    <li>Grundy SM,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stone&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NJ,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bailey&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AL,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; et&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; al.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Guideline&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Management&nbsp; of&nbsp; Blood&nbsp; Cholesterol:&nbsp; A&nbsp; Report&nbsp; of&nbsp; the&nbsp; American&nbsp; College&nbsp; of&nbsp; Cardiology/American&nbsp; Heart&nbsp; Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol2019;73:e285-e350.</li>
    <li>Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA2003;290:891-7.</li>
    <li>Goff DC, Jr., Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a&nbsp; report&nbsp; of&nbsp; the&nbsp; American &nbsp;College&nbsp; of&nbsp; Cardiology/American&nbsp; Heart&nbsp; Association&nbsp; Task&nbsp; Force&nbsp; on&nbsp; Practice&nbsp; Guidelines. J Am Coll Cardiol2014;63:2935-59.</li>
    <li>Wilson SR,&nbsp; Lin&nbsp; FY,&nbsp; Min&nbsp; JK.&nbsp; Role&nbsp; of&nbsp; coronary&nbsp; artery&nbsp; calcium&nbsp; score&nbsp; and&nbsp; coronary&nbsp; CT&nbsp; angiography&nbsp; in&nbsp; the&nbsp; diagnosis&nbsp; and&nbsp; risk&nbsp; stratification&nbsp; of&nbsp; individuals&nbsp; with&nbsp; suspected&nbsp; coronary&nbsp; artery&nbsp; disease.&nbsp; Curr&nbsp; Cardiol&nbsp; Rep2011;13:271-9.</li>
    <li>Perez de Isla L, Alonso R, Muniz-Grijalvo O, et al. Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study. J Clin Lipidol2018;12:948-57.</li>
    <li>Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med2008;358:1336-45.</li>
    <li>American College&nbsp; of&nbsp; Radiology.&nbsp; ACR&nbsp; Appropriateness&nbsp; Criteria&reg;:&nbsp; Acute&nbsp; Nonspecific&nbsp; Chest&nbsp; Pain&mdash;Low Probability of Coronary Artery Disease. Available at: https://acsearch.acr.org/docs/69401/Narrative/. Accessed September 30, 2020.</li>
    <li>Shah AB, Kirsch J, Bolen MA, et al. ACR Appropriateness Criteria&reg; Chronic Chest Pain-Noncardiac Etiology Unlikely-Low to Intermediate Probability of Coronary Artery Disease. J Am Coll Radiol2018;15:S283-S90.</li>
    <li>Akers SR, Panchal V, Ho VB, et al. ACR Appropriateness Criteria&reg; Chronic Chest Pain-High Probability of Coronary Artery Disease. J Am Coll Radiol2017;14:S71-S80.</li>
    <li>Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol1987;59:23C-30C.</li>
    <li>American College&nbsp; of&nbsp; Radiology.&nbsp; ACR&ndash;NASCI&ndash;SIR&ndash;SPR&nbsp; Practice&nbsp; Parameter&nbsp; for&nbsp; the&nbsp; Performance&nbsp; and&nbsp; Interpretation&nbsp; of&nbsp; Body&nbsp; Computed&nbsp; Tomography&nbsp; Angiography&nbsp; (CTA).&nbsp; Available&nbsp; at:&nbsp; https://www.acr.org/-/media/ACR/Files/Practice-Parameters/body-cta.pdf. Accessed September 30, 2020.</li>
    <li>Joshi PH, Patel B, Blaha MJ, et al. Coronary artery Calcium predicts Cardiovascular events in participants with a low&nbsp;&nbsp; lifetime&nbsp;&nbsp; risk&nbsp;&nbsp; of&nbsp;&nbsp; Cardiovascular&nbsp;&nbsp; disease:&nbsp;&nbsp; The&nbsp;&nbsp; Multi-Ethnic&nbsp;&nbsp; Study&nbsp;&nbsp; of&nbsp;&nbsp; Atherosclerosis&nbsp;&nbsp; (MESA).&nbsp;&nbsp; Atherosclerosis2016;246:367-73.</li>
    <li>Hecht H, Blaha MJ, Berman DS, et al. Clinical indications for coronary artery calcium scoring in asymptomatic patients: Expert consensus statement from the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr2017;11:157-68.</li>
    <li>Dudum R,&nbsp; Dzaye&nbsp; O,&nbsp; Mirbolouk&nbsp; M,&nbsp; et&nbsp; al.&nbsp; Coronary&nbsp; artery&nbsp; calcium&nbsp; scoring&nbsp; in&nbsp; low&nbsp; risk&nbsp; patients&nbsp; with&nbsp; family&nbsp; history of coronary heart disease: Validation of the SCCT guideline approach in the coronary artery calcium consortium. J Cardiovasc Comput Tomogr2019;13:21-25.</li>
    <li>Mitchell JD,&nbsp; Paisley&nbsp; R,&nbsp; Moon&nbsp; P,&nbsp; Novak&nbsp; E,&nbsp; Villines&nbsp; TC.&nbsp; Coronary&nbsp; Artery&nbsp; Calcium&nbsp; and&nbsp; Long-Term&nbsp; Risk&nbsp; of&nbsp; Death,&nbsp; Myocardial&nbsp; Infarction,&nbsp; and&nbsp; Stroke:&nbsp; The&nbsp; Walter&nbsp; Reed&nbsp; Cohort&nbsp; Study.&nbsp; JACC&nbsp; Cardiovasc&nbsp; Imaging2018;11:1799-806.</li>
    <li>Carr JJ, Jacobs DR, Jr., Terry JG, et al. Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death. JAMA Cardiol2017;2:391-99.</li>
    <li>Choi EK,&nbsp; Choi&nbsp; SI,&nbsp; Rivera&nbsp; JJ,&nbsp; et&nbsp; al.&nbsp; Coronary&nbsp; computed&nbsp; tomography&nbsp; angiography&nbsp; as&nbsp; a&nbsp; screening&nbsp; tool&nbsp; for&nbsp; the&nbsp; detection of occult coronary artery disease in asymptomatic individuals. J Am Coll Cardiol2008;52:357-65.</li>
    <li>Heijenbrok-Kal MH,&nbsp; Fleischmann&nbsp; KE,&nbsp; Hunink&nbsp; MG.&nbsp; Stress&nbsp; echocardiography,&nbsp; stress&nbsp; single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am Heart J2007;154:415-23.</li>
    <li>Song KD, Kim SM, Choe YH, et al. Integrated cardiac magnetic resonance imaging with coronary magnetic resonance angiography,&nbsp; stress-perfusion,&nbsp; and&nbsp; delayed-enhancement&nbsp; imaging&nbsp; for&nbsp; the&nbsp; detection&nbsp; of&nbsp; occult&nbsp; coronary artery disease in asymptomatic individuals. Int J Cardiovasc Imaging2015;31 Suppl 1:77-89.</li>
    <li>Weir-McCall JR, Fitzgerald K, Papagiorcopulo CJ, et al. Prevalence of unrecognized myocardial infarction in a low-intermediate risk asymptomatic cohort and its relation to systemic atherosclerosis. Eur Heart J Cardiovasc Imaging2017;18:657-62.</li>
    <li>Mordi IR,&nbsp; Badar&nbsp; AA,&nbsp; Irving&nbsp; RJ,&nbsp; Weir-McCall&nbsp; JR,&nbsp; Houston&nbsp; JG,&nbsp; Lang&nbsp; CC.&nbsp; Efficacy&nbsp; of&nbsp; noninvasive&nbsp; cardiac&nbsp; imaging&nbsp; tests&nbsp; in&nbsp; diagnosis&nbsp; and&nbsp; management&nbsp; of&nbsp; stable&nbsp; coronary&nbsp; artery&nbsp; disease.&nbsp; Vasc&nbsp; Health&nbsp; Risk&nbsp; Manag2017;13:427-37.</li>
    <li>Kondos GT,&nbsp; Hoff&nbsp; JA,&nbsp; Sevrukov&nbsp; A,&nbsp; et&nbsp; al.&nbsp; Electron-beam&nbsp; tomography&nbsp; coronary&nbsp; artery&nbsp; calcium&nbsp; and&nbsp; cardiac&nbsp; events:&nbsp; a&nbsp; 37-month&nbsp; follow-up&nbsp; of&nbsp; 5635&nbsp; initially&nbsp; asymptomatic&nbsp; low-&nbsp;&nbsp; to&nbsp; intermediate-risk&nbsp; adults.&nbsp; Circulation2003;107:2571-6.</li>
    <li>Shaw LJ,&nbsp; Raggi&nbsp; P,&nbsp; Schisterman&nbsp; E,&nbsp; Berman&nbsp; DS,&nbsp; Callister&nbsp; TQ.&nbsp; Prognostic&nbsp; value&nbsp; of&nbsp; cardiac&nbsp; risk&nbsp; factors&nbsp; and&nbsp; coronary artery calcium screening for all-cause mortality. Radiology2003;228:826-33.</li>
    <li>Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol2007;49:1860-70.</li>
    <li>Okwuosa TM, Greenland P, Ning H, Liu K, Lloyd-Jones DM. Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study. JACC Cardiovasc Imaging2012;5:923-30.</li>
    <li>Gibson AO, Blaha MJ, Arnan MK, et al. Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study. JACC Cardiovasc Imaging2014;7:1108-15.</li>
    <li>Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA2010;303:1610-6.</li>
    <li>Erbel R,&nbsp; Mohlenkamp&nbsp; S,&nbsp; Moebus&nbsp; S,&nbsp; et&nbsp; al.&nbsp; Coronary&nbsp; risk&nbsp; stratification,&nbsp; discrimination,&nbsp; and&nbsp; reclassification&nbsp; improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol2010;56:1397-406.</li>
    <li>Mulders TA, Taraboanta C, Franken LC, et al. Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease. Atherosclerosis2016;245:155-60.</li>
    <li>Nasir K, Rubin J, Blaha MJ, et al. Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ Cardiovasc Imaging2012;5:467-73.</li>
    <li>Di Cesare E, Patriarca L, Panebianco L, et al. Coronary computed tomography angiography in the evaluation of intermediate risk asymptomatic individuals. Radiol Med2018;123:686-94.</li>
    <li>Picano E, Molinaro S, Pasanisi E. The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta-analysis. Cardiovasc Ultrasound2008;6:30.</li>
    <li>Cruz G,&nbsp; Atkinson&nbsp; D,&nbsp; Henningsson&nbsp; M,&nbsp; Botnar&nbsp; RM,&nbsp; Prieto&nbsp; C.&nbsp; Highly&nbsp; efficient&nbsp; nonrigid&nbsp; motion-corrected&nbsp; 3D&nbsp; whole-heart coronary vessel wall imaging. Magn Reson Med2017;77:1894-908.</li>
    <li>Moghari MH,&nbsp; Roujol&nbsp; S,&nbsp; Henningsson&nbsp; M,&nbsp; et&nbsp; al.&nbsp; Three-dimensional&nbsp; heart&nbsp; locator&nbsp; for&nbsp; whole-heart&nbsp; coronary&nbsp; magnetic resonance angiography. Magn Reson Med2014;71:2118-26.</li>
    <li>Schwitter J,&nbsp; Wacker&nbsp; CM,&nbsp; Wilke&nbsp; N,&nbsp; et&nbsp; al.&nbsp; MR-IMPACT&nbsp; II:&nbsp; Magnetic&nbsp; Resonance&nbsp; Imaging&nbsp; for&nbsp; Myocardial&nbsp; Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission&nbsp; computed&nbsp; tomography&nbsp; for&nbsp; the&nbsp; detection&nbsp; of&nbsp; coronary&nbsp; artery&nbsp; disease:&nbsp; a&nbsp; comparative&nbsp; multicentre,&nbsp; multivendor trial. Eur Heart J2013;34:775-81.</li>
    <li>Hendel RC,&nbsp; Abbott&nbsp; BG,&nbsp; Bateman&nbsp; TM,&nbsp; et&nbsp; al.&nbsp; The&nbsp; role&nbsp; of &nbsp;radionuclide&nbsp; myocardial&nbsp; perfusion&nbsp; imaging&nbsp; for&nbsp; asymptomatic individuals. J Nucl Cardiol2011;18:3-15.</li>
    <li>Multimodality Writing&nbsp;&nbsp; Group&nbsp;&nbsp; for&nbsp;&nbsp; Stable&nbsp;&nbsp; Ischemic&nbsp;&nbsp; Heart&nbsp;&nbsp; Disease,&nbsp;&nbsp; Wolk&nbsp;&nbsp; MJ,&nbsp;&nbsp; Bailey&nbsp;&nbsp; SR,&nbsp;&nbsp; et&nbsp;&nbsp; al.&nbsp;&nbsp; ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS&nbsp; 2013&nbsp; multimodality&nbsp; appropriate&nbsp; use&nbsp; criteria&nbsp; for&nbsp; the&nbsp; detection&nbsp; and&nbsp; risk&nbsp; assessment&nbsp; of&nbsp; stable&nbsp; ischemic&nbsp; heart&nbsp; disease:&nbsp; a&nbsp; report&nbsp; of&nbsp; the&nbsp; American&nbsp; College&nbsp; of&nbsp; Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of&nbsp; Echocardiography,&nbsp; American&nbsp; Society&nbsp; of&nbsp; Nuclear&nbsp; Cardiology,&nbsp; Heart&nbsp; Failure&nbsp; Society&nbsp; of&nbsp; America,&nbsp; Heart&nbsp; Rhythm&nbsp; Society,&nbsp; Society&nbsp; for&nbsp; Cardiovascular&nbsp; Angiography&nbsp; and&nbsp; Interventions,&nbsp; Society&nbsp; of&nbsp; Cardiovascular&nbsp; Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Card Fail2014;20:65-90.</li>
    <li>Sarwar A,&nbsp; Shaw&nbsp; LJ,&nbsp; Shapiro&nbsp; MD,&nbsp; et&nbsp; al.&nbsp; Diagnostic&nbsp; and&nbsp; prognostic&nbsp; value&nbsp; of&nbsp; absence&nbsp; of&nbsp; coronary&nbsp; artery&nbsp; calcification. JACC Cardiovasc Imaging2009;2:675-88.</li>
    <li>Blaha MJ, Budoff MJ, DeFilippis AP, et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet2011;378:684-92.</li>
    <li>Cho I, Chang HJ, B OH, et al. Incremental prognostic utility of coronary CT angiography for asymptomatic patients based upon extent and severity of coronary artery calcium: results from the COronary CT Angiography EvaluatioN For Clinical Outcomes InteRnational Multicenter (CONFIRM) study. Eur Heart J2015;36:501-8.</li>
    <li>Dedic A,&nbsp; Ten&nbsp; Kate&nbsp; GJ,&nbsp; Roos&nbsp; CJ,&nbsp; et&nbsp; al.&nbsp; Prognostic&nbsp; Value&nbsp; of&nbsp; Coronary&nbsp; Computed&nbsp; Tomography&nbsp; Imaging&nbsp; in&nbsp; Patients at High Risk Without Symptoms of Coronary Artery Disease. Am J Cardiol2016;117:768-74.</li>
    <li>Plank F,&nbsp; Friedrich&nbsp; G,&nbsp; Dichtl&nbsp; W,&nbsp; et&nbsp; al.&nbsp; The&nbsp; diagnostic&nbsp; and&nbsp; prognostic&nbsp; value&nbsp; of&nbsp; coronary&nbsp; CT&nbsp; angiography&nbsp; in&nbsp; asymptomatic high-risk patients: a cohort study. Open Heart2014;1:e000096.</li>
    <li>Min JK,&nbsp; Labounty&nbsp; TM,&nbsp; Gomez&nbsp; MJ,&nbsp; et&nbsp; al.&nbsp; Incremental&nbsp; prognostic&nbsp; value&nbsp; of&nbsp; coronary&nbsp; computed&nbsp; tomographic&nbsp; angiography&nbsp; over&nbsp; coronary&nbsp; artery&nbsp; calcium&nbsp; score&nbsp; for&nbsp; risk&nbsp; prediction&nbsp; of&nbsp; major&nbsp; adverse&nbsp; cardiac&nbsp; events&nbsp; in&nbsp; asymptomatic diabetic individuals. Atherosclerosis2014;232:298-304.</li>
    <li>Muhlestein JB, Lappe DL, Lima JA, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA2014;312:2234-43.</li>
    <li>Guaricci AI,&nbsp; Lorenzoni&nbsp; V,&nbsp; Guglielmo&nbsp; M,&nbsp; et&nbsp; al.&nbsp; Prognostic&nbsp; relevance&nbsp; of&nbsp; subclinical&nbsp; coronary&nbsp; and&nbsp; carotid&nbsp; atherosclerosis in a diabetic and nondiabetic asymptomatic population. Clin Cardiol2018;41:769-77.</li>
    <li>Halon DA, Lavi I, Barnett-Griness O, et al. Plaque Morphology as Predictor of Late Plaque Events in Patients With Asymptomatic&nbsp; Type&nbsp; 2&nbsp; Diabetes:&nbsp; A&nbsp; Long-Term &nbsp;Observational&nbsp; Study.&nbsp; JACC&nbsp; Cardiovasc&nbsp; Imaging2019;12:1353-63.</li>
    <li>Beller E,&nbsp; Meinel&nbsp; FG,&nbsp; Schoeppe&nbsp; F,&nbsp; et&nbsp; al.&nbsp; Predictive&nbsp; value&nbsp; of&nbsp; coronary&nbsp; computed&nbsp; tomography&nbsp; angiography&nbsp; in&nbsp; asymptomatic individuals with diabetes mellitus: Systematic review and meta-analysis. J Cardiovasc Comput Tomogr2018;12:320-28.</li>
    <li>Takx RA, Blomberg BA, El Aidi H, et al. Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive&nbsp; coronary&nbsp; angiography&nbsp; with&nbsp; fractional&nbsp; flow&nbsp; reserve&nbsp; meta-analysis.&nbsp; Circ&nbsp; Cardiovasc&nbsp; Imaging2015;8:1-7.</li>
    <li>Young LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA2009;301:1547-55.</li>
    <li>Zellweger MJ, Maraun M, Osterhues HH, et al. Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy. JACC Cardiovasc Imaging2014;7:1001-10.</li>
    <li>Budoff MJ,&nbsp; Raggi&nbsp; P,&nbsp; Beller&nbsp; GA,&nbsp; et&nbsp; al.&nbsp; Noninvasive&nbsp; Cardiovascular&nbsp; Risk&nbsp; Assessment&nbsp; of&nbsp; the&nbsp; Asymptomatic&nbsp; Diabetic&nbsp; Patient:&nbsp; The&nbsp; Imaging&nbsp; Council&nbsp; of&nbsp; the&nbsp; American&nbsp; College&nbsp; of&nbsp; Cardiology.&nbsp; JACC&nbsp; Cardiovasc&nbsp; Imaging2016;9:176-92.</li>
    <li>American College&nbsp; of&nbsp; Radiology.&nbsp; ACR&nbsp; Appropriateness&nbsp; Criteria&reg;&nbsp; Radiation&nbsp; Dose&nbsp; Assessment&nbsp; Introduction.&nbsp; Available&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; at:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; https://www.acr.org/-/media/ACR/Files/Appropriateness-Criteria/RadiationDoseAssessmentIntro.pdf. Accessed September 30, 2020.</li>
</ol>
</body>
</html>